Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients

Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients

Item
http://www.wikidata.org/entity/Q24804838
Apolipoprotein A-I: insights from redox proteomics for its role in neurodegenerationOptimization and evaluation of surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry for protein profiling of cerebrospinal fluid.Protein extraction and 2-DE of water- and lipid-soluble proteins from bovine pericardium, a low-cellularity tissueProteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.Cerebrospinal fluid markers of idiopathic intracranial hypertension: is the renin-angiotensinogen system involved?Abnormal expression of homeobox genes and transthyretin in C9ORF72 expansion carriersQuantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.Increasing proteome coverage for gel-based human tear proteome maps: towards a more comprehensive profiling.Immunoproteomic identification of bovine pericardium xenoantigensUbiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic strokeProteomic profiling of cerebrospinal fluid in Creutzfeldt-Jakob disease.Prion Protein Interactome: Identifying Novel Targets in Slowly and Rapidly Progressive Forms of Alzheimer's Disease.Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.Beta2-microglobulin as a diagnostic marker in cerebrospinal fluid: a follow-up study.Lipolysis is altered in MHC class I zinc-alpha(2)-glycoprotein deficient mice.
P2860

Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients

Item
http://www.wikidata.org/entity/Q24804838
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Validation of a prefractionati ...... ontotemporal dementia patients
@ast
Validation of a prefractionati ...... ontotemporal dementia patients
@en
Validation of a prefractionati ...... ontotemporal dementia patients
@nl
type
label
Validation of a prefractionati ...... ontotemporal dementia patients
@ast
Validation of a prefractionati ...... ontotemporal dementia patients
@en
Validation of a prefractionati ...... ontotemporal dementia patients
@nl
prefLabel
Validation of a prefractionati ...... ontotemporal dementia patients
@ast
Validation of a prefractionati ...... ontotemporal dementia patients
@en
Validation of a prefractionati ...... ontotemporal dementia patients
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Validation of a prefractionati ...... ontotemporal dementia patients
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P932